Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,716,889,091
+$547,786,303 QoQ
Shares Held
2,265,150
-4.0% QoQ
Ownership
0.241%
of shares outstanding
% of Portfolio
1.42%
of 13F equity value
Holder Rank
#42
of 4,632 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Swiss National Bank holds $9,526,453,117 across 11 Drug Manufacturers - General names. LLY ranks #1 (28.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
2,265,150 | $2,716,889,091 | |
| 2 | JNJ |
Johnson & Johnson
|
6,793,407 | $1,725,321,575 | |
| 3 | ABBV |
AbbVie Inc.
|
4,988,710 | $1,255,358,984 | |
| 4 | AZN |
Astrazeneca PLC
|
5,934,315 | $1,125,264,810 | |
| 5 | MRK |
Merck & Co., Inc.
|
6,973,251 | $896,062,753 | |
| 6 | AMGN |
Amgen Inc
|
1,520,393 | $550,564,713 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,500,700 | $442,278,438 | |
| 8 | PFE |
Pfizer Inc
|
16,043,812 | $386,334,992 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,716,889,091 | 2,265,150 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $2,169,102,788 | 2,358,310 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $2,369,143,027 | 2,204,510 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,771,830,970 | 2,322,190 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,901,421,780 | 2,439,190 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,879,597,718 | 2,275,790 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,761,850,680 | 2,282,190 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $2,124,386,666 | 2,397,890 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $2,166,384,210 | 2,392,790 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,879,932,560 | 2,416,490 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $1,470,876,206 | 2,523,290 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,394,008,117 | 2,595,290 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,368,150,664 | 2,917,290 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,100,760,691 | 3,205,290 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $1,200,866,141 | 3,282,490 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $1,131,740,520 | 3,500,048 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,138,516,785 | 3,511,448 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,008,522,974 | 3,521,748 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $853,671,168 | 3,090,548 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $744,708,345 | 3,223,148 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $762,453,504 | 3,321,948 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $722,171,018 | 3,865,598 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $641,507,242 | 3,799,498 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $575,723,493 | 3,889,498 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $647,016,633 | 3,940,898 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $543,768,250 | 3,919,898 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||